Goldman Sachs’s Kindred Biosciences, Inc. KIN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | – | Sell |
|
|||||
2021
Q2 | $2.44M | Buy |
|
|||||
2021
Q1 | $947K | Buy |
|
|||||
2020
Q4 | $578K | Sell |
|
|||||
2020
Q3 | $597K | Buy |
|
|||||
2020
Q2 | $476K | Buy |
|
|||||
2020
Q1 | $165K | Buy |
|
|||||
2019
Q4 | $238K | Sell |
|
|||||
2019
Q3 | $988K | Buy |
|
|||||
2019
Q2 | $115K | Buy |
|
|||||
2019
Q1 | $113K | Sell |
|
|||||
2018
Q4 | $360K | Sell |
|
|||||
2018
Q3 | $715K | Buy |
|
|||||
2018
Q2 | $149K | Sell |
|
|||||
2018
Q1 | $125K | Buy |
|
|||||
2017
Q4 | – | Sell |
|
|||||
2017
Q3 | $384K | Buy |
|
|||||
2017
Q2 | $133K | Sell |
|
|||||
2017
Q1 | $157K | Buy |
|
|||||
2016
Q4 | $74K | Sell |
|
|||||
2016
Q3 | $118K | Sell |
|
|||||
2016
Q2 | $100K | Buy |
|
|||||
2016
Q1 | $87K | Buy |
|
|||||
2015
Q4 | $85K | Sell |
|
|||||
2015
Q3 | $137K | Sell |
|
|||||
2015
Q2 | $579K | Buy |
|
|||||
2014
Q3 | – | Sell |
|
|||||
2014
Q2 | $262K | Buy |
|